An Exactech bankruptcy filing has been announced, indicating that the medical manufacturer will restructure and sell itself to investor groups to resolve lawsuits over recalled knee and hip implants.
The first bellwether trial in the federal Valsartan MDL will involve claims brought by an Alabama man diagnosed with liver cancer, which is the injury most commonly reported among former users of the recalled blood pressure drug.
